PARLODEL (bromocriptine mesylate)
PARLODEL is indicated for the treatment of Hyperprolactinemia; Amenorrhea; Galactorrhea; Infertility; Hypogonadism; Prolactin-Secreting Adenoma; Acromegaly; Parkinson's Disease.
How PARLODEL Works
Bromocriptine is a semi-synthetic ergot alkaloid that acts as a potent dopamine D2 receptor agonist and a partial D1 receptor antagonist. It inhibits the secretion of prolactin from the anterior pituitary by stimulating D2 receptors on lactotroph cells. In patients with acromegaly, it paradoxically suppresses the release of growth hormone. In the treatment of Parkinson’s disease, bromocriptine directly stimulates postsynaptic dopamine receptors in the corpus striatum, helping to compensate for the deficiency of endogenous dopamine.
Details
- Status
- Prescription
- First Approved
- 1978-06-28
- Routes
- ORAL
- Dosage Forms
- TABLET, CAPSULE
PARLODEL Approval History
What PARLODEL Treats
8 indicationsPARLODEL is approved for 8 conditions since its original approval in 1978. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Hyperprolactinemia
- Amenorrhea
- Galactorrhea
- Infertility
- Hypogonadism
- Prolactin-Secreting Adenoma
- Acromegaly
- Parkinson's Disease
PARLODEL Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to PARLODEL
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT02078440 | VS-PEDS BA-2010 | Ph 1 | completed | Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PARLODEL FDA Label Details
Indications & Usage
FDA Label (PDF)PARLODEL is indicated for the treatment of Hyperprolactinemia; Amenorrhea; Galactorrhea; Infertility; Hypogonadism; Prolactin-Secreting Adenoma; Acromegaly; Parkinson's Disease.
Track PARLODEL with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.